Core Viewpoint - Huafeng Co., Ltd. (002806.SZ) is actively advancing a significant transaction and will remain suspended from trading until further developments are confirmed [1] Group 1 - As of the announcement date, the company is engaged in discussions and evaluations regarding specific transaction plans [1] - The company anticipates that it will not resume trading on November 26, 2025, as initially expected [1] - To ensure fair information disclosure and protect investor interests, the company has applied for an extension of its trading suspension, which is expected to last no more than three trading days [1]

截至本公告披露日，相关各方正在积极推进本次重大事项的各项工作，就具体交易方案等相关事项进行 进一步论证和磋商，公司预计无法在2025年11月26日(星期三)开市起复牌。公司股票自2025年11月26日 (星期三)开市起继续停牌，预计停牌时间不超过3个交易日。 华锋股份（002806）(002806.SZ)发布公告，公司收到控股股东、实际控制人及董事长谭帼英女士通 知，获悉其与陈运先生于2025年11月22日签署了《股权转让意向协议》。该事项可能导致公司控股股 东、实际控制人发生变更，具体方案尚需进一步论证和磋商。公司股票已于11月24日开市起停牌。 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 格隆汇11月25日丨华锋股份(002806.SZ)公布，截至本公告披露日，相关各方正在积极推进本次重大事 项的各项工作，就具体交易方案等相关事项进行进一步论证和磋商，公司预计无法在2025年11月26日 （星期三）开市起复牌。为保证公平信息披露，维护投资者利益，避免造成公司股价异常波动，根据 《深圳证券交易所股票上市规则》和《深圳证券交易所上市公司信息披露指引第6号——停复牌》等相 关规定，经公司向深圳证券交易所申请，公司股票（证券简称：华锋股份，股票代码：002806）自2025 年11月26日（星期三）开市起继续停牌，预计停牌时间不超过3个交易日。 ...

截至本公告披露日，相关各方正在积极推进本次重大事项的各项工作，就具体交易方案等相关事项进行 进一步论证和磋商，公司预计无法在2025年11月26日(星期三)开市起复牌。公司股票自2025年11月26日 (星期三)开市起继续停牌，预计停牌时间不超过3个交易日。 智通财经APP讯，华锋股份(002806.SZ)发布公告，公司收到控股股东、实际控制人及董事长谭帼英女士 通知，获悉其与陈运先生于2025年11月22日签署了《股权转让意向协议》。该事项可能导致公司控股股 东、实际控制人发生变更，具体方案尚需进一步论证和磋商。公司股票已于11月24日开市起停牌。 ...

证券代码：002806 证券简称：华锋股份 公告编号：2025-084 广东华锋新能源科技股份有限公司 关于筹划控制权变更暨继续停牌的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 公司收到控股股东、实际控制人及董事长谭帼英女士通知，获悉其与陈运先 生于 2025 年 11 月 22 日签署了《股权转让意向协议》。该事项可能导致公司控股 股东、实际控制人发生变更，具体方案尚需进一步论证和磋商。鉴于上述事项尚 存在重大不确定性，为保证公平信息披露，维护投资者利益，避免造成公司股价 异常波动，经公司向深圳证券交易所申请，公司股票（证券简称：华锋股份，股 票代码：002806）自 2025 年 11 月 24 日（星期一）开市起停牌，预计停牌时间 不超过 2 个交易日。具体情况详见公司于 2025 年 11 月 24 日在巨潮资讯网 （www.cninfo.com.cn）披露的《关于筹划控制权变更的停牌公告》（公告编号： 2025-081）。 1 二、交易进展情况及继续停牌事项的说明 特别提示： 1、广东华锋新能源科技股份有限公司（以下简称"公司"）股票（证券 ...

重要的消息有哪些 1．在回答日方将在与中国台湾邻近的西南诸岛部署进攻性武器的提问时，外交部发言人毛宁24日在例行记者会上表示，此举刻意制造地区紧张，挑动军事对立， 联系到日本首相高市早苗的涉台错误言论，这一动向极其危险，需要引起周边国家及国际社会的高度警惕。中方绝不允许日本右翼势力开历史倒车，绝不允许外部 势力染指中国台湾地区，绝不允许日本军国主义死灰复燃。中方有决心有能力捍卫国家领土主权。（新华社） 4．11月24日下午，4家民营股权投资机构在北京金融资产交易所开展专场路演，拟发行科创债合计9.3亿元。这将是第二批获得央行科技创新债券风险分担工具支持 的项目，这也标志着更多民营股权投资机构在政策支持下通过银行间债券市场融资。 5．据国家发展改革委价格监测中心监测，本轮成品油调价周期内（11月10日—11月21日）国际油价波动下行。本次油价调整具体情况如下：从11月24日24时起，国 内汽、柴油每吨分别下调70元和65元。 6．11月24日，国家能源局发布1—10月份全国电力工业统计数据。截至10月底，全国累计发电装机容量37.5亿千瓦，同比增长17.3%。其中，太阳能发电装机容量 11.4亿千瓦，同比增长4 ...

Core Viewpoint - The controlling shareholder and chairman of Huafeng Co., Tan Guoying, has decided to relinquish control of the company after over 20 years, with Chen Yun set to acquire control, amid Huafeng's declining financial performance [1][2]. Group 1: Ownership Change - On November 22, Tan Guoying signed a share transfer intention agreement with Chen Yun, who plans to acquire Tan's shares either in a lump sum or in installments, along with voting rights [2][3]. - As of the announcement date, Tan Guoying holds approximately 42.8 million shares, representing 20.14% of Huafeng's total share capital [3]. Group 2: Financial Performance - Huafeng's financial performance has been poor, with net profits showing consecutive losses from 2022 to 2024, and the company reported a net loss of approximately 9.93 million in the first three quarters of this year [5]. - Revenue figures for Huafeng from 2022 to 2024 are approximately 658 million, 719 million, and 1.031 billion respectively, with corresponding net profits of -9.61 million, -324 million, and 85.48 million [5]. Group 3: Business Background of Chen Yun - Chen Yun is not a newcomer to the capital market, having co-founded two listed companies, Helitai and Sanlipu, and currently controls Shengbaolai Optoelectronics Technology Co., which focuses on various optical products [3][4]. - Shengbaolai, founded in 2010, has a registered capital of 64 million and is involved in the production and sales of automotive films, optical films, and other related products [4]. Group 4: Market Reactions and Future Considerations - The market is concerned about whether Huafeng's business will shift towards the polarizer sector, given Chen Yun's background, which differs from Huafeng's current focus on electric control and drive systems for new energy vehicles [6]. - Prior to the suspension of trading, Huafeng's stock price fell by 4.13% to 13.22 yuan per share, with a total market capitalization of approximately 2.809 billion [7].

带领华锋股份（002806）走过逾20年后，控股股东、实际控制人及董事长谭帼英决定让出公司的控制权。11月24日早间，华锋股份披 露筹划易主停牌公告，当日午间揭晓了公司的接盘方，陈运拟取得公司控制权，公司股票自11月24日起停牌。在陈运的履历上，可以 看到合力泰、三利谱两家上市公司的身影，其曾任两家公司联合创始人，目前旗下主要资产系胜宝莱光电科技有限公司（以下简称"胜 宝莱"）。此次易主背后，华锋股份近年来业绩表现并不理想，2022—2024年扣非后归属净利润接连亏损，2025年前三季度公司净利、 扣非后归属净利润也均处于亏损状态。 具体来看，陈运出生于1975年9月，曾担任合力泰联合创始人、董事、副总经理，但于2018年退出。据悉，合力泰2008年登陆A股市 场，在消费电子、智能家居、智能金融数据终端、工业控制及自动化、民生能源、健康医疗、车载电子等领域为全球提供液晶触控显 示模组和OLED触显模组等综合解决方案。 此外，陈运还曾任另一家上市公司三利谱的联合创始人、董事、副总经理。2017年上市的三利谱主要从事偏光片产品的研发、生产和 销售，主要产品包括TFT系列和黑白系列偏光片两类。 截至公告披露日，陈运 ...

Group 1 - Huafeng Co., Ltd. announced a stock suspension due to a potential change in control after signing a share transfer intention agreement [1] - Keshida plans to reduce its shareholding by up to 424,000 shares, representing 0.07% of its total share capital [1] - Jinqilin intends to distribute a cash dividend of 0.10 yuan per share, totaling 19.61 million yuan [1] Group 2 - Rejingshi Biotech has repurchased 904,100 shares, accounting for 0.98% of its total share capital, with a total expenditure of 150 million yuan [2] - Yishitong has repurchased 1,236,500 shares, representing 0.619% of its total share capital, with a total expenditure of approximately 33.49 million yuan [2] Group 3 - Hanjia Design announced the release of a detention on its subsidiary's chairman, allowing him to resume duties [4] - Qingmu Technology plans to acquire 65.83% of Vitalis Pharma AS for 300 million Norwegian Krone (approximately 212 million yuan) [4] - Anda Intelligent's shareholder plans to reduce its stake by up to 2.74% [4] Group 4 - Wansheng Intelligent is a candidate for a project with a pre-bid amount of approximately 42.99 million yuan, representing 4.56% of its audited revenue for 2024 [4] - Yipin Hong received a drug registration certificate for a medication used to treat Alzheimer's symptoms [4] Group 5 - *ST Sansheng received a total of 254 million yuan from restructuring investors [4] - Haichuang Pharmaceutical received approval for clinical trials of HP518 tablets for advanced prostate cancer treatment [4] Group 6 - Ningbo Huaxiang's subsidiary plans to invest 5 million yuan in a venture capital fund focusing on intelligent industries [4] - Petty Co. plans to repurchase shares worth 50 to 70 million yuan [4] Group 7 - Tongji Technology's subsidiary won a construction project with a bid price of 866 million yuan [4] - Prolo Pharmaceutical received a drug registration certificate for a generic drug [4] Group 8 - Jingyan Technology plans to use up to 1.6 billion yuan of idle funds for financial management [4] - Furan De received government subsidies totaling 34.65 million yuan [4] Group 9 - David Medical's subsidiary's medical device registration has been accepted [4] - Jusaylong plans to increase its subsidiary's capital by 170 million yuan through debt-to-equity conversion [4] Group 10 - Heng Rui Pharmaceutical's application for a drug license has been accepted by the National Medical Products Administration [4] - Lege Co. plans to increase its stake in the company by 40 to 80 million yuan [4] Group 11 - New Beiyang's subsidiary won a project with the Bank of Communications [4] - Jiangxi Changyun plans to publicly transfer land use rights and buildings with a starting price of 7.79 million yuan [4] Group 12 - Shenqi Pharmaceutical's subsidiary has paid approximately 16.67 million yuan in tax and penalties [4] - Panjiang Co. plans to invest 1.334 billion yuan in a power plant project [4] Group 13 - Fashilong's vice president resigned for personal reasons [4] - Chunxue Food received government subsidies of 3.79 million yuan [4] Group 14 - China Galaxy completed the repayment of a short-term financing bond totaling 3.025 billion yuan [4] - Jiuzhou Pharmaceutical received approval for a chemical raw material drug [4] Group 15 - Longqi Technology's subsidiary plans to invest 30 million yuan in a venture capital fund [4]

证券代码：002806 证券简称：华锋股份 公告编号：2025- 083 广东华锋新能源科技股份有限公司 关于召开 2025 年第三次临时股东大会的提示性公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或 重大遗漏。 广东华锋新能源科技股份有限公司（以下简称"公司"）分别于 2025 年 11 月 11 日、 2025 年 11 月 15 日在巨潮资讯网（www.cninfo.com.cn）披露了《关于召开 2025 年第三次 临时股东大会的通知》（公告编号：2025-077）《关于召开 2025 年第三次临时股东大会的 通知的补充公告》（2025-079）。公司决定于 2025 年 11 月 26 日采用现场表决与网络投票 相结合的方式召开公司 2025 年第三次临时股东大会。现发布本次股东大会的提示性公告， 提醒公司股东及时参加本次股东大会并行使表决权。具体内容如下： 一、召开会议的基本情况 （二）股东大会的召集人：董事会 （三）本次会议的召集、召开符合《中华人民共和国公司法》《深圳证券交易所股票 上市规则》《深圳证券交易所上市公司自律监管指引第 1 号——主板上市 ...